{
  "docId": "019de074-a9ac-701c-b608-a7d685a23a86",
  "docSlug": "61bfab17df32945e4c5e1e9eb8b915b7",
  "documentTitle": "argenx SE | Investor Presentation Deck | 22 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 22,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a three-column layout for clinical data and a footer for scientific validation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-a9ac-701c-b608-a7d685a23a86/8",
  "deckHref": "/decks/019de074-a9ac-701c-b608-a7d685a23a86",
  "deckJsonHref": "/decks/019de074-a9ac-701c-b608-a7d685a23a86.json",
  "deckAnchorHref": "/decks/019de074-a9ac-701c-b608-a7d685a23a86#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.28,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "IgG reduction (%) in all ADAPT-SC and ADAPT participants",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00205a79-9eba-4f29-adfa-ad914011c4e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.28,
        "x": 0.36,
        "y": 0.25
      },
      "kind": "chart",
      "text": "LS-Mean Platelet Count Change From Baseline",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e5b8fbb-2e89-4682-aeb7-1df818a29d23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.08,
        "y": 0.78
      },
      "kind": "image",
      "text": "Scientific journal logos",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bfbf749-a2be-4941-b1b4-96c50200ec9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.7,
        "y": 0.25
      },
      "kind": "list",
      "text": ">1,300 clinical study subjects; Cyclic and chronic dosing; Cumulative exposure of >1,000 patient years; TEAEs consistent across >4 indications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7579ed65-eb23-4706-8761-a4191c2564b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.72
      },
      "kind": "title",
      "text": "Solidifying FcRn Leadership with Deep Repertoire of Preclinical and Translational Data",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60704407-81ee-4d0c-a4c5-76a8f38eb9ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "2022: Strengthened Efgartigimod Data Story",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c70c300-41e6-4475-8fc1-248a07f895ef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 21,
      "from": 7,
      "beatId": "5f17aabc-eb4c-4e3b-b30e-070b7656292a",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "How",
      "beatSlug": "golden-circle-how",
      "evidence": "The presentation finally explains 'how' (pipeline and growth potential)",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 21,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "9faf6166-e0e0-46b6-9e29-f48774efbe4d",
      "evidence": "The presentation uses a golden circle framework to explain the company's mission and growth potential",
      "position": 0,
      "objective": "Explain the company's mission and growth potential",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.8,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}